Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGD6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | IGFBP6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SHROOM4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BET1L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DMTN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MYO1C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | MBD2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CEACAM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DNAJB2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MSH5-SAPCD1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |